Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients
Pierre-Étienne Heudel, Bertrand Favier, Marie-Laure Solodky, Souad Assaad, Natacha Chaumard, Olivier Trédan, Thomas Bachelot, I. L. Ray-Coquard, Bruno Russias, Marie‐Line Fournier, Bénédicte Mastroïanni, Virginie Avrillon, Anne‐Sophie Michallet, Philippe Zrounba, Sylvie Chabaud, David Pérol, Jean‐Yves Blay
Topics & Concepts
MedicineVaccinationCancerClinical endpointInternal medicinePopulationCoronavirus disease 2019 (COVID-19)CohortCohort studyImmunologyClinical trialDiseaseEnvironmental healthInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchCOVID-19 and healthcare impactsLymphadenopathy Diagnosis and Analysis